Synopsis of recent research by authors named "Shenglin Ma"
- Shenglin Ma's recent research focuses on identifying and validating biomarkers for immunotherapy in cancer treatment, particularly through the analysis of immune cells in the tumor microenvironment and the role of IL7R in modulating CD8+ T cell responses at the single-cell level.
- The studies also delve into the mechanistic understanding of drug transporters, such as reduced folate carrier (RFC) and proton-coupled folate transporter (PCFT), in non-small cell lung cancer, and explore the efficacy of combining treatments like Oleandrin with radiotherapy to enhance sensitivity in cancer therapies.
- Additionally, Ma's work includes comprehensive pan-cancer analyses of genetic factors, such as SEPT9 and ITGB4, evaluating their prognostic implications in lung cancer, emphasizing the need for early detection and effective treatment strategies in aggressive cancer forms.
